Behavioural and pharmacological characterisation of the elevated “zero-maze” as an animal model of anxiety
- Journal
- Psychopharmacology
In The Last Decade
doi.org/10.1007/bf02244871 →Countries where authors are citing Behavioural and pharmacological characterisation of the elevated “zero-maze” as an animal model of anxiety
This map shows the geographic impact of Behavioural and pharmacological characterisation of the elevated “zero-maze” as an animal model of anxiety. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Behavioural and pharmacological characterisation of the elevated “zero-maze” as an animal model of anxiety with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Behavioural and pharmacological characterisation of the elevated “zero-maze” as an animal model of anxiety more than expected).
Fields of papers citing Behavioural and pharmacological characterisation of the elevated “zero-maze” as an animal model of anxiety
This network shows the impact of Behavioural and pharmacological characterisation of the elevated “zero-maze” as an animal model of anxiety. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Behavioural and pharmacological characterisation of the elevated “zero-maze” as an animal model of anxiety.
About Behavioural and pharmacological characterisation of the elevated “zero-maze” as an animal model of anxiety
This paper, published in 1994, received 594 indexed citations . Written by Jon K. Shepherd, Savraj Grewal, Allan Fletcher, David J. Bill and Colin T. Dourish covering the research area of Cognitive Neuroscience and Cellular and Molecular Neuroscience. It is primarily cited by scholars working on Cellular and Molecular Neuroscience (259 citations), Behavioral Neuroscience (194 citations) and Social Psychology (158 citations). Published in Psychopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/10.1007/bf02244871.